 Johns Hopkins Kimmel Cancer Center Tops Rankings AgainThe Johns Hopkins Kimmel Cancer Center once again has been ranked third best in the nation and the top cancer hospital in the Mid-Atlantic Region by U.S. News & World Report. Johns Hopkins Hospital earned the top spot among all hospitals in the annual rankings for the 17th year in a row.
 Colon Cancer Proteins Show Promise For Blood TestSearching for less invasive screening tests for cancer, Johns Hopkins scientists have discovered proteins present in blood that accurately identify colon cancer and precancerous polyps. Initial studies of the proteins, CCSA-3 and CCSA-4, suggest they could be used to develop a blood test to identify at-risk individuals.
 Johns Hopkins Researchers at Clinical Cancer MeetingsThe following news tips are based on abstracts by Johns Hopkins Kimmel Cancer Center researchers presented at the 43rd annual meeting of the American Society of Clinical Oncology held June 1-5, 2007 in Chicago. GENE TYPE PREDICTS BREAST CANCER DRUG'S SIDE EFFECT - For most women taking the drug tamoxifen to prevent breast cancer or its recurrence, there is a trade-off -- hot flashes -- the unexpected blast of body heat that occurs when hormonal changes affect a woman's ability to regulate internal body temperature. Now, researchers at the Johns Hopkins Kimmel Cancer Center, Indiana University, and University of Michigan have found that subtle differences in a common breast cancer gene can predict who gets the "hot" side effect. DOCTORS DIFFER IN POSTTREATMENT PREVENTION SERVICES - Cancer survivors who visit both primary care providers and cancer specialists are more likely to get preventive care services, such as flu shots, mammograms, and cervical cancer screening according to a preliminary analysis by Johns Hopkins researchers.
  Johns Hopkins Announces New Cancer Survivors ProgramThe Johns Hopkins Kimmel Cancer Center announces the launch of a new program to address the long-term needs of cancer patients. The Michael J. Garil Leukemia Survivors Program supports research designed to better understand the long-term effects of therapy and to offer such follow up services as screening and prevention strategies for children and adults with leukemia. The new program was established with a gift from Ethel and Bernard Garil.
|
